Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | Cesium carbonate | HCID 10796 | — |
| Reactant | tert-Butyl bromoacetate | HCID 79177 | — |
| Reactant | 1-(4-Fluorophenyl)-3-(3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one | HCID 4979942 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Product | HCID 69199501 | HCID 69199501 | 55% |
Reaction Steps
1-(4-Fluorophenyl)-3-[3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl) azetidin-2-one (J. Med. Chem. 1998, 41, 973-980; 50 mg, 0.122 mmol), tert-butylbromoacetate (24 μl, 0.165 mmol), sodium carbonate (80 mg, 0.76 mmol) and a catalytic amount of caesium carbonate were added to MeCN (3 ml) and the mixture was stirred for 1.5 hours at 50° C. The solids were filtered off and the solvent was evaporated under reduced pressure. Purification of the residue by column chromatography using DCM/EtOAc (100/7) as eluent gave 35 mg, (55%) of the title compound. NMR (300 MHz): 1.45 (s, 9H), 1.8-2.1 (m, 4H), 2.25-2.3 (m, 1H), 3.05-3.15 (m, 1H), 4.5 (s, 2H), 4.55-4.6 (m, 1H), 4.75 (bs, 1H), 6.9-7.3 (m, 12H); m/z 524.3.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07470678B2 |
|---|
| Source dataset | uspto-grants-2008_12 |
|---|
| ORD ID | ord-e5e3f62c74094e82b4f61a0e696d0d40 |
|---|
| Source note | uspto-grants-2008_12 |
|---|